Gennex Lab.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE509C01026
  • NSEID:
  • BSEID: 531739
INR
13.49
0.00 (0.00%)
BSENSE

Dec 05

BSE+NSE Vol: 1.68 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Trident Lifeline
Gennex Lab.
Bafna Pharma.
Sanjiv.Parant.
Brooks Lab.
Zenotech Lab.
Lyka Labs
Valiant Laborato
Zim Laboratories
Sat Kartar
Infinium Pharma
Why is Gennex Laboratories Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0.08 times
2
Healthy long term growth as Operating profit has grown by an annual rate 44.14%
3
Negative results in Sep 25
  • INTEREST(9M) At Rs 3.21 cr has Grown at 79.33%
  • PBT LESS OI(Q) At Rs 4.00 cr has Fallen at -34.64%
  • ROCE(HY) Lowest at 8.58%
4
With ROCE of 7, it has a Attractive valuation with a 1.5 Enterprise value to Capital Employed
  • The stock is trading at a fair value compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -28.83%, its profits have risen by 2.2%
5
Majority shareholders : Non Institution
6
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 2.06% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -28.83% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Gennex Lab. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Gennex Lab. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Gennex Lab.
-28.51%
-0.57
50.88%
Sensex
4.84%
0.41
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
22.71%
EBIT Growth (5y)
44.14%
EBIT to Interest (avg)
6.23
Debt to EBITDA (avg)
1.54
Net Debt to Equity (avg)
0.19
Sales to Capital Employed (avg)
0.87
Tax Ratio
13.96%
Dividend Payout Ratio
0
Pledged Shares
17.43%
Institutional Holding
0.00%
ROCE (avg)
12.56%
ROE (avg)
9.64%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
20
Industry P/E
34
Price to Book Value
1.54
EV to EBIT
20.76
EV to EBITDA
18.65
EV to Capital Employed
1.45
EV to Sales
2.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.98%
ROE (Latest)
7.82%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
PAT(Q)

Highest at Rs 5.03 cr.

-14What is not working for the Company
INTEREST(9M)

At Rs 3.21 cr has Grown at 79.33%

PBT LESS OI(Q)

At Rs 4.00 cr has Fallen at -34.64%

ROCE(HY)

Lowest at 8.58%

DEBT-EQUITY RATIO(HY)

Highest at 0.41 times

NON-OPERATING INCOME(Q)

is 33.99 % of Profit Before Tax (PBT

Loading Valuation Snapshot...
Here's what is working for Gennex Lab.
Profit After Tax (PAT) - Quarterly
Highest at Rs 5.03 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Here's what is not working for Gennex Lab.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 4.00 cr has Fallen at -34.64%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Interest - Quarterly
At Rs 1.03 cr has Grown at 102,999,900.00%
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Non Operating Income - Quarterly
is 33.99 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT

Debt-Equity Ratio - Half Yearly
Highest at 0.41 times
in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio